Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7931)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2017 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen J, Wang LF, Zou ZY, Kong WW, Yan J, Meng FY, Chen FJ, Du J, Shao J, Xu QP, Ren HZ, Li RT, Wei J, Qian XP, Liu BR. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(29): 5395-5404 [PMID: 28839440 DOI: 10.3748/wjg.v23.i29.5395] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i29/5395.htm |
| Number | Citing Articles |
| 1 |
Thiago A. Patente, Mariana P. Pinho, Aline A. Oliveira, Gabriela C. M. Evangelista, Patrícia C. Bergami-Santos, José A. M. Barbuto. Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Frontiers in Immunology 2019; 9 doi: 10.3389/fimmu.2018.03176
|
| 2 |
Juan Wang, Zhongmin Li, Zhongtang Wang, Yonghua Yu, Di Li, Baosheng Li, Jianxun Ding. Nanomaterials for Combinational Radio–Immuno Oncotherapy. Advanced Functional Materials 2020; 30(30) doi: 10.1002/adfm.201910676
|
| 3 |
Raheleh Roudi, Alberto D'Angelo, Marianna Sirico, Navid Sobhani. Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects. International Immunopharmacology 2021; 101: 108322 doi: 10.1016/j.intimp.2021.108322
|
| 4 |
Tingting Li, Ciying Qian, Ying Gu, Jun Zhang, Shaowei Li, Ningshao Xia. Current progress in the development of prophylactic and therapeutic vaccines. Science China Life Sciences 2023; 66(4): 679 doi: 10.1007/s11427-022-2230-4
|
| 5 |
Antonia D'Aniello, Alessandra Del Bene, Salvatore Mottola, Vincenzo Mazzarella, Roberto Cutolo, Erica Campagna, Salvatore Di Maro, Anna Messere. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines. Journal of Peptide Science 2024; 30(8) doi: 10.1002/psc.3596
|
| 6 |
Domenico Galati, Serena Zanotta. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies. Cytotherapy 2018; 20(11): 1309 doi: 10.1016/j.jcyt.2018.09.007
|
| 7 |
Wensi Liu, Haichao Tang, Luanfeng Li, Xiangyi Wang, Zhaojin Yu, Jianping Li. Peptide‐based therapeutic cancer vaccine: Current trends in clinical application. Cell Proliferation 2021; 54(5) doi: 10.1111/cpr.13025
|
| 8 |
Miao Wang, Yong-Peng Tong, Qi Luo, Shi-Peng Hu. Study of ATP borate ester effects on cell sensitization to radiation emitted by a nuclear reactor. Nuclear Science and Techniques 2020; 31(1) doi: 10.1007/s41365-019-0713-0
|
| 9 |
Dequan Liu, Lei Liu, Xinghan Li, Shijin Wang, Guangzhen Wu, Xiangyu Che. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective. Vaccines 2024; 12(8): 950 doi: 10.3390/vaccines12080950
|
| 10 |
Noraini Abd-Aziz, Chit Laa Poh, Xiangya Ding. Development of Peptide-Based Vaccines for Cancer. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/9749363
|
| 11 |
Pietro Guerra, Andrea Martini, Patrizia Pontisso, Paolo Angeli. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma. Cancers 2023; 15(14): 3629 doi: 10.3390/cancers15143629
|
| 12 |
Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang, Chunxiao Li. Advances in radiotherapy and immunity in hepatocellular carcinoma. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04386-y
|
| 13 |
Nahla E. El-Ashmawy, Enas A. El-Zamarany, Eman G. Khedr, Hoda A. El-Bahrawy, Ola A. El-Feky. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study. Clinical and Experimental Medicine 2018; 18(4): 535 doi: 10.1007/s10238-018-0521-6
|
| 14 |
Xuan Zhao, Zhen Zhang, Chunli Wen, Jianmin Huang, Shuangning Yang, Jinyan Liu, Huizhen Geng, Bing Peng, Zibo Li, Yi Zhang. The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1284334
|
| 15 |
Liying Sun, Yanzhe Hao, Zhan Wang, Yi Zeng. Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines. Viruses 2018; 10(4): 145 doi: 10.3390/v10040145
|
| 16 |
Leire Bejarano, Marta J.C. Jordāo, Johanna A. Joyce. Therapeutic Targeting of the Tumor Microenvironment. Cancer Discovery 2021; 11(4): 933 doi: 10.1158/2159-8290.CD-20-1808
|
| 17 |
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Abhishek D. Garg. Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 2019; 8(11): 1638212 doi: 10.1080/2162402X.2019.1638212
|
| 18 |
Takumi Kumai, Hidekiyo Yamaki, Michihisa Kono, Ryusuke Hayashi, Risa Wakisaka, Hiroki Komatsuda. Antitumor Peptide-Based Vaccine in the Limelight. Vaccines 2022; 10(1): 70 doi: 10.3390/vaccines10010070
|
| 19 |
Yvonne Chiung-Fang Hsu, Jason Chia-Hsien Cheng. Radiotherapy of Liver Cancer. 2021; : 325 doi: 10.1007/978-981-16-1815-4_23
|
| 20 |
V. E. Mukhin, Yu. S. Konstantinova, R. R. Gimadiev, N. V. Mazurchik. Horizons of development of immunotherapy for malignant liver tumors. Experimental and Clinical Gastroenterology 2021; (7): 81 doi: 10.31146/1682-8658-ecg-191-7-81-89
|
| 21 |
Chou-Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, Atreyi Pramanik, Rajiv Sharma, Faraj Mohammed, Israa Abed Jawad, Imad Jasim Mohammed, Mohammad Y. Alshahrani, Noor Alhuda Mohammad Ali khalil, Ali Turki Shnishil, Munther Kadhim Abosaoda. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles. Pathology - Research and Practice 2024; 256: 155266 doi: 10.1016/j.prp.2024.155266
|
| 22 |
Jing-Jing Du, Zhenhong Su, Haoyi Yu, Sanhai Qin, Dongyuan Wang. From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy. Frontiers in Chemistry 2023; 10 doi: 10.3389/fchem.2022.1107600
|